Cite
HARVARD Citation
García, M. et al. (n.d.). P778 Effectiveness and safety of a second-line rescue therapy for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study). Journal of Crohn's and colitis. pp. i911-i912. [Online].